Biologic Patent Protection: When Do Biosimilars Enter the Market?
Learn how the BPCIA and the 'patent dance' determine when biosimilars enter the U.S. market and why biologic patent protection differs from traditional generics.
Learn how the BPCIA and the 'patent dance' determine when biosimilars enter the U.S. market and why biologic patent protection differs from traditional generics.
Generic drugs save billions in healthcare costs worldwide. Discover the key trends shaping their future - from biosimilars and supply chain risks to India’s manufacturing boom and growing demand in emerging markets.